These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells. Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410 [TBL] [Abstract][Full Text] [Related]
4. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2. Qi J; Pan L; Yu Z; Ni W Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848 [TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844 [TBL] [Abstract][Full Text] [Related]
6. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797 [TBL] [Abstract][Full Text] [Related]
7. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker. Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653 [TBL] [Abstract][Full Text] [Related]
8. mTORC2 regulates hedgehog pathway activity by promoting stability to Gli2 protein and its nuclear translocation. Maiti S; Mondal S; Satyavarapu EM; Mandal C Cell Death Dis; 2017 Jul; 8(7):e2926. PubMed ID: 28703798 [TBL] [Abstract][Full Text] [Related]
9. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795 [TBL] [Abstract][Full Text] [Related]
10. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
11. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related]
12. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1. Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824 [TBL] [Abstract][Full Text] [Related]
13. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587 [TBL] [Abstract][Full Text] [Related]
14. GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells. Huang D; Wang Y; Xu L; Chen L; Cheng M; Shi W; Xiong H; Zalli D; Luo S J Exp Clin Cancer Res; 2018 Oct; 37(1):247. PubMed ID: 30305138 [TBL] [Abstract][Full Text] [Related]
15. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
16. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties. Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656 [TBL] [Abstract][Full Text] [Related]
17. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme. Zhou Y; Dai W; Wang H; Pan H; Wang Q Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460 [TBL] [Abstract][Full Text] [Related]
19. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling. Lu Y; Tian M; Liu J; Wang K J Biochem Mol Toxicol; 2021 Sep; 35(9):e22848. PubMed ID: 34328678 [TBL] [Abstract][Full Text] [Related]
20. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma. Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]